[Ip-health] FTC v. Actavis: Post Argument Discussion (Supreme Court case on pharmaceutical reverse payments)

Michael Palmedo mpalmedo at wcl.american.edu
Fri Mar 22 07:44:41 PDT 2013

FTC v. Actavis: Post-Argument Discussion


March 25, 2013 | 4:00-5:30pm | Room 602

American University Washington College of Law

CLE Available for In-Person Attendees


For Live Webcast and More Info:


In PIJIP's ongoing Supreme Court series, counsel for respondents,
counsel for amici, and other legal experts will discuss intellectual
property cases on the afternoon of oral argument, addressing the
reaction of the Court at oral argument. 


Reverse payment agreements are a type of settlement agreement where
brand-name drug manufacturers pay potential generic competitors to agree
not to sell competing generic drugs for a period of years.


In this case the Supreme Court examines whether reverse-payment
agreements are per se lawful unless the underlying patent litigation was
a sham or the patent was obtained by fraud (as the court below held), or
instead are presumptively anticompetitive and unlawful (as the Third
Circuit has held).


This Monday, PIJIP is pleased to welcome Counsel of Record for
Respondents along with Counsel for Amici, to discuss the Supreme Court
oral argument and the implications of this case:


- Michael Carroll - Washington College of Law, Moderator 

- Julia York - Skadden, Arps, Slate, Meagher & Flom LLP, counsel for
Respondent, Actavis, Inc.

- Rohit Singla - Munger, Tolles & Olson LLP, counsel for Respondent,
Solvay Pharmaceuticals, Inc.

- Ryan Christian - White & Case LLP, counsel for Respondent, Par
Pharmaceutical Companies, Inc.

- Krista Cox - Knowledge Ecology International, counsel for amicus,
Knowledge Ecology International

- Scott Hemphill - Columbia Law School



Mike Palmedo

Program on Information Justice and Intellectual Property

American University Washington College of Law

4801 Massachusetts Ave., NW, Washington, D.C. 20016

W: 202-274-4442 | M: 571-289-3683

wcl.ameican.edu | infojustice.org | pijip-impact.org



More information about the Ip-health mailing list